Difference between revisions of "Template:Article of the month"

From CannaQAWiki
Jump to navigationJump to search
(Updated article of the month text)
(Updated article of the month text)
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig1 Ennia CompTherMed2022 66.jpg|220px]]</div>
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig3 Johnson JofCannRes23 5.png|220px]]</div>
'''"[[Journal:Academic-industry partnership advancing cannabis science: The Complementary Care Practice-Based Research Network|Academic-industry partnership advancing cannabis science: The Complementary Care Practice-Based Research Network]]"'''
'''"[[Journal:Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem|Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem]]"'''


Data collected during routine care holds the potential to support hypothesis generation, study feasibility, and provide insight regarding how to address problems under real world conditions. Currently there are no practice-based research networks in Florida that focus on complementary care in general or [[Cannabis (drug)|medical marijuana]] specifically. Through an academic-industry partnership, we sought to develop a practice-based research network focused on ''[[Cannabis]]'' science and create a de-identified database for [[Data analysis|analyses]] that support hypothesis generation, study feasibility estimation, and a network that also facilitates recruitment into future research studies ... ('''[[Journal:Academic-industry partnership advancing cannabis science: The Complementary Care Practice-Based Research Network|Full article...]]''')<br />
[[Hemp]]-derived [[Tetrahydrocannabinol|delta-9-tetrahydrocannabinol]] (Δ<sup>9</sup>-THC) products are freely available for sale across much of the USA, but the federal legislation allowing their sale places only minimal requirements on companies. Products must contain no more than 0.3% Δ<sup>9</sup>-THC by dry weight, but no limit is placed on overall dosage, and there is no requirement that products derived from hemp-based Δ<sup>9</sup>-THC be tested. However, some states—such as Colorado—specifically prohibit products created by “chemically modifying” a natural hemp component ... ('''[[Journal:Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem|Full article...]]''')<br />
<br />
<br />


''Recently featured'':
''Recently featured'':
: ▪ [[Journal:Beyond cannabinoids: Application of NMR-based metabolomics for the assessment of Cannabis sativa L. crop health|Beyond cannabinoids: Application of NMR-based metabolomics for the assessment of ''Cannabis sativa'' L. crop health]]
: ▪ [[Journal:A metabolomics and big data approach to cannabis authenticity (authentomics)|A metabolomics and big data approach to cannabis authenticity (authentomics)]]
: ▪ [[Journal:High-throughput methods to identify male Cannabis sativa using various genotyping methods|High-throughput methods to identify male Cannabis sativa using various genotyping methods]]
: ▪ [[Journal:Cadmium bioconcentration and translocation potential in day-neutral and photoperiod-sensitive hemp grown hydroponically for the medicinal market|Cadmium bioconcentration and translocation potential in day-neutral and photoperiod-sensitive hemp grown hydroponically for the medicinal market]]
: ▪ [[Journal:Effects of the storage conditions on the stability of natural and synthetic cannabis in biological matrices for forensic toxicology analysis: An update from the literature|Effects of the storage conditions on the stability of natural and synthetic cannabis in biological matrices for forensic toxicology analysis: An update from the literature]]
: ▪ [[Journal:High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method|High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method]]

Latest revision as of 23:21, 30 November 2023

Fig3 Johnson JofCannRes23 5.png

"Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem"

Hemp-derived delta-9-tetrahydrocannabinol (Δ9-THC) products are freely available for sale across much of the USA, but the federal legislation allowing their sale places only minimal requirements on companies. Products must contain no more than 0.3% Δ9-THC by dry weight, but no limit is placed on overall dosage, and there is no requirement that products derived from hemp-based Δ9-THC be tested. However, some states—such as Colorado—specifically prohibit products created by “chemically modifying” a natural hemp component ... (Full article...)

Recently featured:

▪ A metabolomics and big data approach to cannabis authenticity (authentomics)
▪ Cadmium bioconcentration and translocation potential in day-neutral and photoperiod-sensitive hemp grown hydroponically for the medicinal market
▪ High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method
Retrieved from "https://www.cannaqa.wiki/index.php?title=Template:Article_of_the_month&oldid=18494"